APTAMER GROUP PLC Logo

APTAMER GROUP PLC

Develops custom affinity binders for research, diagnostics, and therapeutics.

APTA | IL

Overview

Corporate Details

ISIN(s):
GB00BNRRP542
LEI:
213800Y4XGH3WJNBE686
Country:
United Kingdom
Address:
WINDMILL HOUSE, YO10 5BR YORK

Description

Aptamer Group PLC is a life sciences company that develops custom affinity binders to address targeting challenges in research, diagnostics, and therapeutics. The company's core technology is the Optimer® platform, which discovers and develops proprietary, next-generation aptamer-based binders. These Optimer binders are engineered for high specificity, stability, and manufacturability. The company provides custom development services, partnering with global pharmaceutical, diagnostic, and biotechnology organizations to support their programs from early discovery through to clinical development. Key application areas include the development of novel therapeutics, advanced diagnostic assays, bioprocessing workflows, and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 14:15
Results of 2025 Annual General Meeting
English 11.0 KB
2025-11-27 08:20
AGM Statement
English 15.1 KB
2025-11-14 08:20
Strong contract wins build commercial momentum
English 32.6 KB
2025-11-04 08:25
New contract with top five pharma company
English 14.8 KB
2025-11-03 08:30
Posting of Annual Report and Notice of AGM
English 11.3 KB
2025-10-14 08:00
Full Year Results for the 12mths to 30 June 2025
English 640.3 KB
2025-10-13 08:00
New contract with top 10 pharma
English 15.7 KB
2025-10-10 08:00
Notice of Results, Analyst & Investor Presentation
English 13.3 KB
2025-09-11 08:00
New contract with Metir plc
English 17.0 KB
2025-09-09 08:00
Notification of dealings by a director/PDMR
English 23.8 KB
2025-09-02 08:00
Therapeutic development agreement with Invizius
English 18.4 KB
2025-08-28 08:00
Block Listing Interim Review
English 14.9 KB
2025-08-22 08:00
Update on licensing and development progress
English 19.5 KB
2025-08-19 08:00
Exercise of warrants
English 13.5 KB
2025-08-18 08:00
Contract extension with global pharma partner
English 14.7 KB

Automate Your Workflow. Get a real-time feed of all APTAMER GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for APTAMER GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for APTAMER GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.